Featured Research

from universities, journals, and other organizations

Giving Smaller Doses Of Chemotherapy More Frequently May Attack Tumor Blood Supply

Date:
March 28, 2001
Source:
Jefferson Medical College
Summary:
Radiation oncologists at Thomas Jefferson University Hospital are rethinking how to give chemotherapy, taking advantage of its unique properties. They are giving chemotherapy more frequently than usual and in tinier doses, targeting the process by which a new blood supply is created feeding tumor growth, called angiogenesis.

Radiation oncologists at Thomas Jefferson University Hospital are rethinking how to give chemotherapy, taking advantage of its unique properties. They are giving chemotherapy more frequently than usual and in tinier doses, targeting the process by which a new blood supply is created feeding tumor growth, called angiogenesis.

Related Articles


Traditionally, most cancer therapies are used in highest possible doses, says Adam Dicker, M.D., Ph.D., assistant professor of radiation oncology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and at Jefferson’s Kimmel Cancer Center. But anti-angiogenesis drugs have caused people to rethink chemotherapy. “Instead of targeting the tumor, perhaps you can target the tumor-associated blood supply,” he says.

Dr. Dicker and his Jefferson co-workers studied the chemotherapy drug docitaxel (Taxotere) in the laboratory in lower-than-usual doses, about one-tenth the clinical dose. They wanted to see the effects of radiation and the drug, which makes cancer cells more vulnerable to radiation, on endothelial cells, which are involved in angiogenesis. They found the lower doses of drug affect different parameters of angiogenesis and can increase the effects with radiation. “This is a unique approach in combination therapy, targeting the vasculature,” Dr. Dicker said.

Dr. Dicker will present the group’s findings March 27 at the annual meeting of the American Association for Cancer Research meeting in New Orleans.

“What’s unique about this is that we’ve used a common chemotherapy agent in an antiangiogenic manner and potentiated that,” Dr. Dicker says. “This area is particularly interesting because these drugs, which are FDA approved, can have antiangiogenic effects.

“It’s a totally new way of thinking, it’s completely changed the paradigm,” says Dr. Dicker. “With all the interest in anti-angiogenesis, you can rethink how you give chemotherapy and radiation.”

According to Dr. Dicker, recent research have shown dramatic effects with conventional chemotherapy, but used in a different way. Instead of using large doses infrequently, every three weeks or so, for example, giving the time the body needs to recover from chemotherapy, preclinical studies have been using lower doses more frequently, maybe twice a week.

They next plan to take this approach, using low-dose docetaxel and radiation therapy, in a study in lung cancer together with colleague Maria Werner-Wasik, M.D., assistant professor of radiation oncology at Jefferson Medical College.


Story Source:

The above story is based on materials provided by Jefferson Medical College. Note: Materials may be edited for content and length.


Cite This Page:

Jefferson Medical College. "Giving Smaller Doses Of Chemotherapy More Frequently May Attack Tumor Blood Supply." ScienceDaily. ScienceDaily, 28 March 2001. <www.sciencedaily.com/releases/2001/03/010328075705.htm>.
Jefferson Medical College. (2001, March 28). Giving Smaller Doses Of Chemotherapy More Frequently May Attack Tumor Blood Supply. ScienceDaily. Retrieved October 26, 2014 from www.sciencedaily.com/releases/2001/03/010328075705.htm
Jefferson Medical College. "Giving Smaller Doses Of Chemotherapy More Frequently May Attack Tumor Blood Supply." ScienceDaily. www.sciencedaily.com/releases/2001/03/010328075705.htm (accessed October 26, 2014).

Share This



More Health & Medicine News

Sunday, October 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins